Editor's Note Patients taking SGLT2 inhibitors face a higher risk of postoperative euglycemic ketoacidosis (eKA) but experience fewer acute kidney injuries and deaths after surgery, according to an April 30 article in Medical Xpress. The article focuses on new research published in JAMA Surgery. Led by researchers at the University…